Document ID: chunk:federal_register_of_legislation:F2023L01670:clause:1_3
Version: federal_register_of_legislation:F2023L01670
Segment Type: clause
Provision Reference: sch 1 cl 3
Character Range: 3598–4361

3  Schedule 1, (cell at item 38522, column 2)
Repeal the cell, substitute:
       TAVI, for the treatment of symptomatic severe native calcific aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if:
       (a) the TAVI Patient is at low risk for surgery; and
       (b) the service:
             (i) is performed by a TAVI Practitioner in a TAVI Hospital; and
             (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and
             (iii) includes valvuloplasty, if required;
       not being a service which has been rendered within 5 years of a service to which this item or item 38495 or 38514 applies (H) (Anaes.) (Assist.)